SEC Tracker
Get the app
CNSY · XBRL financial data

Cerenome financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CNSY's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Apr 1, 2026Jun 30, 2026
Revenue—year only1,6771,2791,4561,412*1,0591,3901,3971,367*—411
Research and development2,4932,794*2,7632,7732,8582,186*1,7561,2462,4362,941*—4,265
General and administrative1,9982,379*2,2132,2032,3973,126*2,8391,6823,4434,168*—5,203
Total operating expenses4,4915,173*4,9764,9765,2555,312*4,5952,9285,8797,109*—9,468
Operating income (loss)(3,251)(3,860)*(3,299)(3,697)(3,799)(3,900)*(3,536)(1,538)(4,482)(5,742)*—(9,057)
Interest income119110*72678054*1275929*—56
Interest expense8762*34276157*5480*0*0*—5
Income tax expense (benefit)—year only———year only———year only——
Net income (loss)(3,219)(3,810)*(3,261)(2,940)(2,874)(3,903)*(17,401)5,151(4,423)(5,713)*—(9,006)
Earnings per share, basic‡ USD per share(25.00)—(18.75)(11.25)(9.25)—(29.75)0.50(1.00)——(1.31)
Earnings per share, diluted‡ USD per share(25.00)—(18.75)(17.75)(9.25)(12.50)*(29.75)(0.25)(1.00)——(1.31)
Weighted average shares, basic‡ thousands of shares129—173260314314*5831,9364,297——6,899
Weighted average shares, diluted‡ thousands of shares129—173430314315*5838,3664,297——6,899
  • ‡ Per-share figures and share counts are adjusted for the 1-for-25 stock split (April 2026); filings made before it reported them unadjusted.
  • † Share count changed about 3x in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (CNSY's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Apr 1, 2026Jun 30, 2026
Cash and cash equivalents11,0068,5542,9014,9121,223769,8672,23313,2894,256—2,366
Short-term investments——3233,5233,5653,530—4,6463,3124,356—6,221
Total current assets11,5849,8344,2139,3805,3645,25910,8689,21417,58615,170—11,771
Property and equipment, net1,009906800732591448324289273257—1,409
Right-of-use asset2322021711391067338292070—43
Goodwill372372372372372372372372372372—372
Total assets13,27811,3885,62111,2126,9786,63312,05610,35018,67016,325—14,030
Accounts payable—4,758———9,474———3,276——
Current portion of long-term debt4,3483,9763,590—————————
Total current liabilities10,53810,72710,39918,78712,11215,55110,5597,31613,61612,314—8,567
Lease liability, non-current1188559504031———15——
Total liabilities10,65612,73610,45818,83712,15215,58235,6977,31613,61612,329—8,567
Accumulated deficit(476,691)(480,501)(483,762)(486,702)(489,576)(493,479)(510,880)(505,729)(510,152)(515,865)—(531,817)
Total stockholders' equity2,622(1,348)(4,837)(7,625)(5,174)(8,949)(23,641)3,0345,0543,996—5,463
Total liabilities and equity13,27811,3885,62111,2126,9786,63312,05610,35018,67016,325—14,030
Common shares outstanding (cover page)‡ thousands of shares1811711712362366801,3093,9715,4976,8626,8837,590
  • ‡ Per-share figures and share counts are adjusted for the 1-for-25 stock split (April 2026); filings made before it reported them unadjusted.
  • † Share count changed about 3x in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (CNSY's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Apr 1, 2026Jun 30, 2026
Net income (loss)(3,219)(3,810)*(3,261)(2,940)(2,874)(3,903)*(17,401)5,151(4,423)(5,713)*—(9,006)
Stock-based compensation148*141*146151*125*128*148152*527*713*—830*
Depreciation and amortization159*151*155170*199*199*14677*77*145*—137*
Net cash from operating activities(2,399)*(1,881)*(4,513)(1,150)*(3,680)*(1,211)*(6,172)(5,798)*(2,548)*(6,257)*—(7,132)*
Purchases of property and equipment10*42*4081*14*11*37*27*30*—499*
Net cash from investing activities(10)*(42)*(364)(3,802)*(9)*64*3,558(4,632)*1,297*(1,077)*—5,366*
Proceeds from issuing common stock2,922*347*——————16,817*3,003*——
Proceeds from issuing equity(2,258)*———0*0*——————
Repayments of long-term debt402*402*4023,594*0*0*——————
Net cash from financing activities2,520*(529)*(776)6,963*0*0*12,4052,796*12,307*2,803*—1,110*
Net change in cash111*(2,452)*(5,653)2,011*(3,689)*(1,147)*9,791(7,634)*11,056*(4,531)*—(656)*
  • † Share count changed about 3x in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Cerenome2,366411(7,132)*7.6M1.2 quarters 10-QJun 30, 2026
QT Imaging Holdings10,9247,435(4,837)*14.6M2.3 quarters 10-QJun 30, 2026
NutriBand3,422438(585)*12.2M— 10-QJul 31, 2026
Femasys1,444332(3,936)*8.4M0.4 quarters 10-QJun 30, 2026
DarioHealth6,634not reported(6,083)*9.8M2.3 quarters 10-QJun 30, 2026
HeartBeam8,722not reported(3,342)*56.3M2.6 quarters 10-QJun 30, 2026
electroCore8,5019,450(3,518)*9.0M2.9 quarters 10-QJun 30, 2026
Nephros4,6976,017681*10.9M— 10-QJun 30, 2026
Modular Medical3,920not reported(5,972)8.2M0.7 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.